| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.2 | 0.0006 |